logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Manufacturers
    3. Boehringer Ingelheim Pharmaceuticals, Inc.

    Boehringer Ingelheim Pharmaceuticals, Inc. drugs

    FiltersReset Filters
    25 results

    • adalimumab - adbm - adalimumab - adbm

      (Adalimumab-Adbm)
      Boehringer Ingelheim Pharmaceuticals, Inc.

    • aptivus - tipranavir capsule, liquid filled

      (Tipranavir)
      Boehringer Ingelheim Pharmaceuticals, Inc.

    • atrovent hfa - ipratropium bromide aerosol, metered

      (Ipratropium Bromide)
      Boehringer Ingelheim Pharmaceuticals, Inc.

    • combivent respimat

      (ipratropium bromide and albuterol)
      Boehringer Ingelheim Pharmaceuticals, Inc.
      Usage: COMBIVENT RESPIMAT is indicated for patients with chronic obstructive pulmonary disease (COPD) who have ongoing bronchospasm and require an additional bronchodilator while using a regular aerosol bronchodilator. It combines ipratropium bromide and albuterol sulfate for enhanced respiratory relief.

    • cyltezo

      (adalimumab-adbm)
      Boehringer Ingelheim Pharmaceuticals, Inc.
      Usage: CYLTEZO is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients aged 2 and older.

    • gilotrif

      (afatinib)
      Boehringer Ingelheim Pharmaceuticals, Inc.
      Usage: GILOTRIF is indicated for first-line treatment of metastatic non-small cell lung cancer (NSCLC) with non-resistant EGFR mutations, and for previously treated metastatic squamous NSCLC progressing after platinum-based chemotherapy. Its safety and efficacy in resistant EGFR mutations are not established.

    • glyxambi - empagliflozin and linagliptin tablet, film coated

      (Empagliflozin And Linagliptin)
      Boehringer Ingelheim Pharmaceuticals, Inc.

    • hernexeos - zongertinib tablet, film coated

      (Zongertinib)
      Boehringer Ingelheim Pharmaceuticals, Inc.

    • jardiance - empagliflozin tablet, film coated

      (Empagliflozin)
      Boehringer Ingelheim Pharmaceuticals, Inc.

    • jascayd

      (Nerandomilast)
      Boehringer Ingelheim Pharmaceuticals, Inc.